Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Smart Tissues
Kyoto, Japan
A
1-10 Employees
2020
Key takeaway
The company is dedicated to advancing bioprinting technologies that enable the creation of realistic 3D human tissues, providing innovative solutions for laboratories engaged in life sciences research. Their focus on developing novel materials and improving product performance underscores their commitment to enhancing bioprinting applications.
Reference
Core business
About us – Smart Tissues
ReproCELL
Yokohama, Japan
A
51-100 Employees
2003
Key takeaway
REPROCELL specializes in translational research, offering a diverse product catalog that supports stem cell research and 3D bioengineered tissues. Their expertise in induced pluripotent stem cells (iPSCs) and a biorepository of ethically-sourced human tissues enhances their capabilities in developing regenerative medicine therapies.
Reference
Product
Products: ABLE® Biott® Bioreactor Systems
Purchase the ABLE® Biott® Bioreactor System from the human tissue and iPSC experts. Request a quote for delivery to the USA or Europe.
ThinkCyte
Tokyo, Japan
A
11-50 Employees
2016
Key takeaway
The company is focused on advancing biology and medicine through innovative therapies and diagnostics. They utilize a novel ultrafast imaging technique combined with artificial intelligence for high-throughput characterization and sorting of cells, which could be relevant to bioprinting applications.
Reference
Product
PLATFORMS Archive - ThinkCyte
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Optieum Biotechnologies
Matsuyama, Japan
A
1-10 Employees
2020
Key takeaway
Optieum Biotechnologies Inc. focuses on innovative technologies, which may include advancements relevant to bioprinting.
Reference
Core business
OPTIEUM BIOTECHNOLOGIES
Stem Cell & Device Laboratory
Kyoto, Japan
A
1-10 Employees
2014
Key takeaway
The company specializes in biomaterials research, highlighting a functional neuron maturation device that enhances applications on microelectrode arrays for measuring neural networks.
Reference
Product
PRODUCTS・SERVICES | Stem Cell & Device Laboratory, Inc.
Minaris Regenerative Medicine
Tokyo, Japan
A
501-1000 Employees
-
Key takeaway
Minaris Regenerative Medicine is a prominent contract development and manufacturing organization specializing in cell and gene therapy products. With over 20 years of experience and state-of-the-art facilities worldwide, they are well-positioned to support the production and supply of innovative therapies.
Reference
Service
QP Batch Certification | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
Molcure
Tokyo, Japan
A
11-50 Employees
2013
Key takeaway
The company specializes in biopharmaceutical data analysis, utilizing proprietary methods and AI technology to discover valuable antibodies and peptides. Their advanced techniques, including directed evolution experiments and machine learning, enhance the drug discovery process.
Reference
Core business
Molcure Inc. | Accelerating drug discovery
Beyond Next Ventures
Tokyo, Japan
A
1-10 Employees
2014
Key takeaway
The company, Beyond Next Ventures, is dedicated to supporting researchers and entrepreneurs in the deep tech sector, including drug discovery and biotechnology. They provide essential resources such as business planning, financial assistance, and access to incubation facilities, which can be crucial for those involved in bioprinting and related innovations.
Reference
Product
Drug discovery / Biotech | Beyond Next Ventures
001
Medmain
Fukuoka, Japan
A
11-50 Employees
2018
Key takeaway
Medmain develops PidPort, an analytical system for pathological image diagnosis that utilizes Deep Learning and AI, enabling highly precise and instantaneous screening of pathological tissues and cells. This innovative approach to medical diagnostics supports practitioners globally, facilitating remote pathological diagnosis and efficient management of medical data.
Reference
Core business
Medmain inc.
To create a world where medical services can be accessed with technology anywhere,anytime-As a supporting partner to medical practitioners throughout the world, Medmain develops and operates PidPort, an analytical system for pathological image diagnosis that makes use of Deep Learning, as well as Medteria, a specialized cloud-based service for medical students.
PhoenixBio
Higashi Hiroshima, Japan
A
51-100 Employees
2002
Key takeaway
PhoenixBio has developed a chimeric mouse model with a humanized liver, enhancing the translational relevance of drug discovery and development projects. This innovative model allows for more effective preclinical drug testing, providing valuable insights into human outcomes.
Reference
Core business
PhoenixBio – a new era of mouse models
Boost the translational quality of drug development and discovery via PhoenixBio’s chimeric mouse model with a humanized liver.
Technologies which have been searched by others and may be interesting for you:
When exploring the bioprinting industry in Japan, several key considerations emerge. The regulatory landscape plays a crucial role, as Japan has stringent guidelines regarding biotechnology and medical devices. Familiarity with the Pharmaceuticals and Medical Devices Agency (PMDA) regulations is essential for compliance and market entry. Additionally, Japan's aging population presents significant opportunities for bioprinting applications in regenerative medicine and tissue engineering. However, challenges such as high research and development costs and competition from established markets like the United States and Europe must be addressed. Environmental concerns are also prevalent, as sustainable practices are increasingly prioritized in manufacturing processes. Companies that emphasize eco-friendly materials and biocompatibility may gain a competitive edge. The competitive landscape in Japan is characterized by a mix of established firms and innovative startups, making collaboration with academic institutions and technology partners vital for success. Furthermore, understanding global market relevance is important, as Japan aims to position itself as a leader in bioprinting technology. Keeping abreast of international trends and advancements can provide strategic insights for navigating this evolving industry. Overall, thorough research into regulatory requirements, market opportunities, environmental sustainability, and competitive dynamics will be essential for anyone interested in the bioprinting sector in Japan.
Some interesting numbers and facts about your company results for Bioprinting
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 29 |
| Amount of suitable service providers | 14 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 2002 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Bioprinting
What are related technologies to Bioprinting?
Based on our calculations related technologies to Bioprinting are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Bioprinting?
The most represented industries which are working in Bioprinting are Other, Biotechnology, IT, Software and Services, Medical, Consulting
How does ensun find these Bioprinting Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.